Also known as Taxotere
Docetaxel (as generic or under the trade name Taxotere) is a clinically well-established anti-mitotic chemotherapy medication (that is, it interferes with cell division). It is used mainly for the treatment of breast, ovarian, prostate, and non-small cell lung cancer. Docetaxel has an FDA approved claim for treatment of patients who have locally advanced, or metastatic breast or non small-cell lung cancer who have undergone anthracycline-based chemotherapy and failed to stop cancer progression or relapsed and a European approval for use in hormone-refractory prostate cancer.Source: Wikipedia
Estimated Total Cost: $2963.86 for an average of 21 days supply
Patients are most commonly prescribed docetaxel to treat breast cancer, prostate cancer, metastatic cancer, and lung cancer.